Xarelto 20 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FJQE8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,383
Award facts
- Contract value 100% obligated
- $16,382.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Xarelto 20 mg tablets in a quantity of 90 units, with a contract ceiling value of $16,382.80. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for ultimate completion by July 23, 2025, and will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company maintains an extensive portfolio of federal medical supply contracts encompassing brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This specific delivery order for Xarelto, an anticoagulant medication, exemplifies the company's role in supporting Department of Defense healthcare procurement through competitively awarded contracts with firm fixed pricing.
Quick answers
Who was awarded contract SPE2DB25FJQE8?
SPE2DB25FJQE8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FJQE8 worth?
The government has obligated $16,383 on SPE2DB25FJQE8.
Is contract SPE2DB25FJQE8 an order under another contract?
Yes. SPE2DB25FJQE8 is a delivery order under SPE2DB22D2005, an indefinite delivery contract.
Was contract SPE2DB25FJQE8 competed?
The extent of competition for SPE2DB25FJQE8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award